Your browser is no longer supported. Please, upgrade your browser.
Settings
MSLI Merus Labs International Inc. daily Stock Chart
MSLI [NASD]
Merus Labs International Inc.
Index- P/E- EPS (ttm)-0.08 Insider Own34.80% Shs Outstand117.71M Perf Week-1.68%
Market Cap137.72M Forward P/E48.75 EPS next Y0.02 Insider Trans0.00% Shs Float110.79M Perf Month51.69%
Income-9.30M PEG- EPS next Q0.01 Inst Own6.90% Short Float1.31% Perf Quarter36.05%
Sales76.60M P/S1.80 EPS this Y71.40% Inst Trans0.33% Short Ratio15.24 Perf Half Y19.98%
Book/sh1.18 P/B0.99 EPS next Y200.00% ROA-3.50% Target Price1.21 Perf Year-15.83%
Cash/sh0.01 P/C137.72 EPS next 5Y- ROE-6.60% 52W Range0.70 - 1.45 Perf YTD34.48%
Dividend- P/FCF44.43 EPS past 5Y36.80% ROI-0.20% 52W High-17.93% Beta1.32
Dividend %- Quick Ratio0.50 Sales past 5Y- Gross Margin65.30% 52W Low69.88% ATR0.05
Employees13 Current Ratio0.80 Sales Q/Q14.70% Oper. Margin-1.00% RSI (14)72.24 Volatility2.80% 2.78%
OptionableNo Debt/Eq0.72 EPS Q/Q68.60% Profit Margin-12.10% Rel Volume0.69 Prev Close1.17
ShortableYes LT Debt/Eq0.55 EarningsMay 10 Payout- Avg Volume95.43K Price1.19
Recom3.00 SMA2027.39% SMA5032.75% SMA20028.83% Volume32,607 Change1.71%
Nov-30-15Initiated CIBC Sector Outperform
May-29-15Initiated TD Securities Buy
May-11-17 01:44PM  Merus Labs Shares Spike 50% on Acquisition TheStreet.com +54.15%
12:07PM  Merck Up on Approval, Teva Sinks on Earnings and Asset Sales: Biotech Movers TheStreet.com
07:36AM  Merus Labs reports 2Q loss Associated Press
07:00AM  Merus Labs Reports Fiscal Q2 2017 Results CNW Group
07:00AM  Merus Labs and Norgine Enter into a Definitive Arrangement Agreement PR Newswire
May-04-17 06:30PM  Merus Labs Announces Key Milestone for Sintrom® Profit Enhancing Initiative CNW Group
Mar-21-17 06:19PM  Merus Announces Re-Election of Directors PR Newswire
06:19PM  Merus Announces Re-Election of Directors CNW Group
Mar-16-17 08:58AM  Merus Labs International, Inc. :MSLI-US: Earnings Analysis: Q1, 2017 By the Numbers : March 16, 2017 Capital Cube
08:58AM  Merus Labs International, Inc. :MSLI-US: Earnings Analysis: Q1, 2017 By the Numbers : March 16, 2017
Mar-13-17 07:00AM  Merus Labs Announces Changes to Stock Option Plan to Address ISS Recommendation PR Newswire +7.24%
07:00AM  Merus Labs Announces Changes to Stock Option Plan to Address ISS Recommendation CNW Group
Feb-28-17 10:40PM  Merus Labs Responds to Reuters News Article PR Newswire
Feb-14-17 07:24AM  Merus Labs reports 1Q loss Associated Press
07:00AM  Merus Labs Reports Fiscal Q1 2017 Results PR Newswire
07:00AM  Merus Labs Reports Fiscal Q1 2017 Results CNW Group
Feb-09-17 09:10PM  Merus Labs Announces Date of Fiscal Q1 2017 Earnings Release PR Newswire
Jan-09-17 08:47AM  What Makes Merus Labs (MSLI) a Strong Sell? Zacks
Jan-06-17 01:04PM  MERUS LABS INTERNATIONAL INC. Financials
Dec-23-16 08:15AM  Blog Coverage Ionis Pharma Records Three Milestones Payment Within a Week Accesswire +8.91%
Dec-21-16 08:19AM  Merus Labs International, Inc. :MSLI-US: Earnings Analysis: 2016 By the Numbers : December 21, 2016 Capital Cube
08:19AM  Merus Labs International, Inc. :MSLI-US: Earnings Analysis: 2016 By the Numbers : December 21, 2016
Dec-14-16 07:30AM  Merus Labs Reports Fiscal Q4 and 2016 Results PR Newswire -20.32%
Dec-12-16 09:22PM  Merus Labs Announces Date of Fiscal 2016 Earnings Release PR Newswire
Nov-16-16 05:06PM  Merus Receives Nasdaq Notice Regarding Minimum Bid Price Requirements PR Newswire +5.99%
Oct-12-16 07:00AM  Barry Fishman Joins Aurora Board as Independent Director CNW Group
Oct-03-16 08:00AM  Merus Labs Announces Reduced Interest Rate on Senior Secured Debt and Reduced Leverage PR Newswire
Aug-22-16 08:43AM  What Falling Estimates & Price Mean for Merus Labs International (MSLI)
Aug-15-16 11:21AM  Merus Labs reports 3Q loss -23.34%
07:00AM  Merus Labs Reports Fiscal Q3 2016 Results PR Newswire
Aug-10-16 12:30PM  Merus Labs to Present at U.S. Investor Conference and Announces Date of Fiscal Q3 2016 Earnings Release PR Newswire
Jul-04-16 07:00AM  Merus Announces Reduced Leverage and Provides Business Update PR Newswire
Jun-30-16 04:00PM  Merus Labs Appoints Two New Senior Executives PR Newswire
May-18-16 04:24PM  Merus Labs International Inc. Announces Deemed Exercise of Special Warrants PR Newswire -5.59%
04:20PM  Merus Labs International Inc. Announces Deemed Exercise of Special Warrants CNW Group
May-11-16 05:56PM  Merus Labs reports 2Q loss
04:00PM  Merus Labs Reports Fiscal Q2 2016 Results PR Newswire
Mar-30-16 09:44PM  Merus announces re-election of directors PR Newswire +5.00%
Mar-07-16 07:56AM  Merus Completes Acquisition of Surgestone®, Provames®, Tredemine® and Speciafoldine® Rights from Sanofi PR Newswire
Mar-01-16 09:05AM  Merus Labs International Inc. Announces Closing Of $27 Million Bought Deal Financing PR Newswire
09:04AM  Merus Labs International Inc. announces closing of $27 million bought deal financing CNW Group
Feb-23-16 07:30AM  Merus Announces Inaugural Deal with Sanofi PR Newswire
Feb-19-16 07:58AM  Merus announces $27 million bought deal PR Newswire -7.33%
Feb-11-16 04:05PM  Merus Labs Reports Solid Fiscal Q1 2016 Results PR Newswire
Feb-04-16 06:03PM  Merus completes acquisition of Elantan®, Isoket® and Deponit® rights from UCB and announces date of Q1 2016 earnings release PR Newswire
Feb-01-16 02:52PM  Merus Reaches Agreement to Acquire Three Cardiovascular Products PR Newswire +10.20%
Dec-07-15 04:05PM  Merus Reports Fiscal 2015 Results and Provides Business Update PR Newswire -7.15%
Dec-01-15 05:00PM  Merus Labs to Host Conference Call on Year End Results PR Newswire
Nov-20-15 08:15AM  Merus Labs International (MSLI) Jumps: Stock Rises 6.4%
Oct-21-15 07:30PM  Merus Labs Announces Filing of Audited June 30, 2015 Financial Statements PR Newswire
Oct-05-15 11:19AM  Slow Growth Ahead; Updates on Merus Labs International, Enghouse Systems, Athabasca Minerals
Sep-09-15 08:37AM  What Falling Estimates & Price Mean for Merus Labs International (MSLI)
Aug-10-15 07:00PM  Merus Labs Reports Q3 2015 Results PR Newswire
Jul-10-15 07:00AM  Merus Labs Announces Filing of Preliminary Base Shelf Prospectus PR Newswire +7.49%
Jun-03-15 04:00PM  Merus Labs Provides an Update on German Reimbursement Review PR Newswire
Jun-01-15 09:24AM  Merus Labs International Inc. Announces Closing of Exercise of Over-Allotment Option PR Newswire +7.69%
May-29-15 08:04AM  Coverage initiated on Merus Labs by TD Securities
May-28-15 07:00AM  Merus Labs to Present at Jefferies 2015 Healthcare Conference in New York PR Newswire
May-26-15 11:23AM  Merus Labs Appoints Frank Rotmann VP & Head of European Operations PR Newswire
May-22-15 07:00AM  Merus Labs Acquires Specialty Product Rights in Multiple Countries PR Newswire
May-13-15 04:00PM  Merus Labs Reports Strong Q2 2015 Results PR Newswire
May-11-15 05:00PM  Merus Labs to Host Q2 Results Conference Call PR Newswire
Apr-30-15 09:59AM  Merus Labs International Inc. announces closing of c$60.0 million bought deal financing PR Newswire
09:58AM  Merus Labs International Inc. announces closing of $60.0 million bought deal financing CNW Group
Apr-13-15 11:56AM  March 27, 2015 Merus Labs Appoints New Director and Provides European Update at noodls
09:35AM  Canada Stocks to Watch: AuRico, Alamos, Merus and more at The Wall Street Journal
Mar-27-15 08:00AM  Merus Labs Appoints New Director and Provides European Update PR Newswire
Mar-02-15 08:00AM  Merus Labs announces settlement of Canadian patent litigation PR Newswire
Feb-11-15 04:00PM  Merus Labs Announces Record Q1 2015 Results Marketwired
Feb-09-15 04:45AM  Merus Labs Appoints Geoff Morrow as Vice President, Business Development at noodls
Feb-04-15 08:00AM  Merus Labs Appoints Geoff Morrow as Vice President, Business Development Marketwired
Dec-18-14 04:00PM  Merus Labs International Inc. Announces Results for Fiscal 2014 Marketwired
Dec-15-14 03:00PM  Merus Labs International Inc. Appoints Barry Fishman as Chief Executive Officer Marketwired
Nov-17-14 08:00AM  Merus Labs International Inc. Announces Normal Course Issuer Bid Marketwired
Nov-10-14 02:38PM  SUNRISE HOLDINGS LTD Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial Statements a EDGAR Online
Oct-31-14 11:28AM  SUNRISE HOLDINGS LTD Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Oct-28-14 09:46AM  Merus Labs International Inc (MSLI) Downgraded From Hold to Sell at TheStreet
Oct-20-14 04:33PM  3 Stocks Moving The Drugs Industry Upward at TheStreet
Oct-17-14 04:32PM  3 Stocks Boosting The Health Care Sector Higher at TheStreet
Merus Labs International Inc., a specialty pharmaceutical company, is engaged in the acquisition and licensing of branded prescription medicines in the United States, Canada, and Europe. It offers Emselex/Enablex, a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency; and Vancocin, an antibiotic used to treat diseases resulting from the infection of Clostridium Difficile. The company serves wholesalers and distributors, physicians and allied health professionals, patients and their families/caregivers, managed care organizations and group purchasing organizations, and state and federal government health agencies. Merus Labs International Inc. is headquartered in Toronto, Canada.